Published in Cancer Treat Rev on March 10, 2008
Adaptive therapy. Cancer Res (2009) 2.81
Hypoxia, notch signalling, and prostate cancer. Nat Rev Urol (2013) 2.24
The complexities of obesity and diabetes with the development and progression of pancreatic cancer. Biochim Biophys Acta (2010) 1.29
Fisetin induces autophagic cell death through suppression of mTOR signaling pathway in prostate cancer cells. Carcinogenesis (2010) 1.17
Prostate cancer cell lines under hypoxia exhibit greater stem-like properties. PLoS One (2011) 1.05
Impact of hypoxia on the metastatic potential of human prostate cancer cells. Int J Radiat Oncol Biol Phys (2011) 1.04
The role of hypoxia-inducible factor 1α in determining the properties of castrate-resistant prostate cancers. PLoS One (2013) 0.94
Poly (ADP-ribose) polymerase inhibitor: an evolving paradigm in the treatment of prostate cancer. Asian J Androl (2014) 0.92
The effects of nonspecific HIF1α inhibitors on development of castrate resistance and metastases in prostate cancer. Cancer Med (2014) 0.91
Hypoxia-inducible miR-182 enhances HIF1α signaling via targeting PHD2 and FIH1 in prostate cancer. Sci Rep (2015) 0.91
Noninvasive multiparametric imaging of metastasis-permissive microenvironments in a human prostate cancer xenograft. Cancer Res (2009) 0.90
Old but new methods in radiation oncology: hyperbaric oxygen therapy. Int J Clin Oncol (2013) 0.90
Liposomal doxorubicin improves radiotherapy response in hypoxic prostate cancer xenografts. Radiat Oncol (2011) 0.87
MicroRNAs as putative mediators of treatment response in prostate cancer. Nat Rev Urol (2012) 0.86
Angiogenesis inhibitors in the treatment of prostate cancer. Expert Opin Pharmacother (2010) 0.86
Inhibition of Hypoxia Inducible Factor Alpha and Astrocyte-Elevated Gene-1 Mediates Cryptotanshinone Exerted Antitumor Activity in Hypoxic PC-3 Cells. Evid Based Complement Alternat Med (2012) 0.85
Distinct phenotypes of human prostate cancer cells associate with different adaptation to hypoxia and pro-inflammatory gene expression. PLoS One (2014) 0.84
Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer. Radiat Oncol (2012) 0.84
The nrf1 and nrf2 balance in oxidative stress regulation and androgen signaling in prostate cancer cells. Cancers (Basel) (2010) 0.83
Rapid detection of hypoxia-inducible factor-1-active tumours: pretargeted imaging with a protein degrading in a mechanism similar to hypoxia-inducible factor-1alpha. Eur J Nucl Med Mol Imaging (2010) 0.82
Hypoxic tumor kinase signaling mediated by STAT5A in development of castration-resistant prostate cancer. PLoS One (2013) 0.79
To die or to survive, a fatal question for the destiny of prostate cancer cells after androgen deprivation therapy. Cancers (Basel) (2011) 0.78
Beyond the limits of oxygen: effects of hypoxia in a hormone-independent prostate cancer cell line. ISRN Oncol (2013) 0.76
Chronic pulmonary disease negatively influences the prognosis of patients with advanced prostate cancer. World J Urol (2009) 0.76
Methylseleninic acid elevates REDD1 and inhibits prostate cancer cell growth despite AKT activation and mTOR dysregulation in hypoxia. Cancer Med (2014) 0.76
Clinical Response of Metastatic Breast Cancer to Multi-targeted Therapeutic Approach: A Single Case Report. Cancers (Basel) (2011) 0.75
Hypoxia regulates Notch-3 mRNA and receptor activation in prostate cancer cells. Heliyon (2016) 0.75
Exposure of Prostate to Lipopolysaccharide and Hypoxia Potentiates Neoplastic Behavior and Risk for Prostate Carcinogenesis In Vivo. Int Sch Res Notices (2014) 0.75
K63-polyubiquitinated HAUSP deubiquitinates HIF-1α and dictates H3K56 acetylation promoting hypoxia-induced tumour progression. Nat Commun (2016) 0.75
Downregulation of key regulatory proteins in androgen dependent prostate tumor cells by oncolytic reovirus. Virology (2015) 0.75
Oxygen supply maps for hypoxic microenvironment visualization in prostate cancer. J Pathol Inform (2016) 0.75
Fractionated radiation exposure amplifies the radioresistant nature of prostate cancer cells. Sci Rep (2016) 0.75
A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med (1996) 9.85
A brief mental health outcome scale-reliability and validity of the Global Assessment of Functioning (GAF). Br J Psychiatry (1995) 3.65
Lymph node recovery from colorectal resection specimens removed for adenocarcinoma. Trends over time and a recommendation for a minimum number of lymph nodes to be recovered. Am J Clin Pathol (1996) 3.52
Autosomal dominant retinitis pigmentosa (ADRP): localization of an ADRP gene to the long arm of chromosome 3. Genomics (1989) 2.52
Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trial. Gene Ther (2008) 1.88
Activated protein C inhibits lipopolysaccharide-induced nuclear translocation of nuclear factor kappaB (NF-kappaB) and tumour necrosis factor alpha (TNF-alpha) production in the THP-1 monocytic cell line. Br J Haematol (2000) 1.51
The prothrombin gene variant G20210A but not factor V leiden may be associated with veno-occlusive disease following BMT. Bone Marrow Transplant (1999) 1.43
Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanoma. Gene Ther (2008) 1.41
Infection of donor lymphocytes with human T lymphotrophic virus type 1 (HTLV-I) following allogeneic bone marrow transplantation for HTLV-I positive adult T-cell leukaemia. Br J Haematol (1994) 1.41
Dendritic cells and T cells deliver oncolytic reovirus for tumour killing despite pre-existing anti-viral immunity. Gene Ther (2009) 1.40
Evidence of genetic resistance of cattle to infection with Mycobacterium bovis. J Dairy Sci (2010) 1.32
Universal vs. risk factor-based screening for gestational diabetes mellitus: detection rates, gestation at diagnosis and outcome. Diabet Med (2000) 1.27
Constitutive activation of 5-lipoxygenase in the lungs of patients with idiopathic pulmonary fibrosis. J Clin Invest (1996) 1.22
Autosomal dominant retinitis pigmentosa: a new multi-allelic marker (D3S621) genetically linked to the disease locus (RP4). Hum Genet (1991) 1.16
Autosomal dominant retinitis pigmentosa: linkage to rhodopsin and evidence for genetic heterogeneity. Genomics (1990) 1.14
Neuregulin 1 (8p12) and childhood-onset schizophrenia: susceptibility haplotypes for diagnosis and brain developmental trajectories. Mol Psychiatry (2006) 1.12
The influence of cyclosporin alone, or cyclosporin and methotrexate, on the incidence of mixed haematopoietic chimaerism following allogeneic sibling bone marrow transplantation for severe aplastic anaemia. Bone Marrow Transplant (2006) 1.08
Synergistic cytotoxicity of oncolytic reovirus in combination with cisplatin-paclitaxel doublet chemotherapy. Gene Ther (2012) 1.08
Enhancement of seed oil content by expression of glycerol-3-phosphate acyltransferase genes. Biochem Soc Trans (2000) 1.07
Characterization of protein C receptor expression in monocytes. Br J Haematol (2001) 1.06
Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring. Leukemia (2006) 1.06
Reovirus therapy stimulates endoplasmic reticular stress, NOXA induction, and augments bortezomib-mediated apoptosis in multiple myeloma. Oncogene (2011) 1.04
Pyrrolo-1,5-benzoxazepines induce apoptosis in chronic myelogenous leukemia (CML) cells by bypassing the apoptotic suppressor bcr-abl. J Pharmacol Exp Ther (2001) 1.04
The EuroChimerism concept for a standardized approach to chimerism analysis after allogeneic stem cell transplantation. Leukemia (2012) 0.99
The role of Hispanic race/ethnicity and poverty in breast cancer survival. P R Health Sci J (1995) 0.99
Activated protein C inhibits tumor necrosis factor and macrophage migration inhibitory factor production in monocytes. Eur Cytokine Netw (2000) 0.97
Reolysin is a novel reovirus-based agent that induces endoplasmic reticular stress-mediated apoptosis in pancreatic cancer. Cell Death Dis (2013) 0.95
Novel pyrrolo-1,5-benzoxazepine compounds display significant activity against resistant chronic myeloid leukaemia cells in vitro, in ex vivo patient samples and in vivo. Br J Cancer (2010) 0.95
Partial biotinidase deficiency: clinical and biochemical features. J Pediatr (1990) 0.95
Donor-cell leukemia after bone marrow transplantation for severe aplastic anemia. N Engl J Med (1991) 0.95
Feasibility and efficacy of a supervised exercise intervention in de-conditioned cancer survivors during the early survivorship phase: the PEACH trial. J Cancer Surviv (2013) 0.94
A prospective study to identify high-yield criteria associated with acute intracranial computed tomography findings in head-injured patients. Am J Emerg Med (1993) 0.94
Utility of predictive equations for estimating the prevalence and incidence of primary open angle glaucoma in the UK. Br J Ophthalmol (2000) 0.93
Randomized comparison of unfractionated heparin with corticosteroids in severe active inflammatory bowel disease. Aliment Pharmacol Ther (2000) 0.92
Treatment of relapse after allogeneic bone marrow transplantation with reduced intensity conditioning (FLAG +/- Ida) and second allogeneic stem cell transplant. Br J Haematol (2001) 0.92
Ventilation and gas exchange during sleep in patients with interstitial lung disease. Thorax (1986) 0.91
Colon resection with primary anastomosis performed as an emergency and as a non-planned operation. Ann Surg (1967) 0.91
Epidermolysis bullosa: evidence for linkage to genetic markers on chromosome 1 in a family with the autosomal dominant simplex form. Genomics (1990) 0.90
Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites. Int J Cancer (2013) 0.90
(18)FDG uptake during induction chemoradiation for oesophageal cancer fails to predict histomorphological tumour response. Br J Cancer (2006) 0.89
Immune haemolytic anaemia following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukaemia: association with leukaemic relapse and treatment with donor lymphocyte infusions. Bone Marrow Transplant (2001) 0.87
Genetic parameters for production, health, fertility and longevity traits in dairy cows. Animal (2012) 0.87
The emergence of DNA methylation as a key modulator of aberrant cell death in prostate cancer. Endocr Relat Cancer (2008) 0.87
Increased cholesterol in plasma in a young man during experimental copper depletion. Metabolism (1984) 0.86
Prolonged reduction of high blood pressure with an in vivo, nonpathogenic, adeno-associated viral vector delivery of AT1-R mRNA antisense. Hypertension (1997) 0.86
Organochlorine chemicals in tree swallows nesting in pool 15 of the Upper Mississippi River. Bull Environ Contam Toxicol (2000) 0.86
Recovery: what mental health nurses and service users say about the concept of recovery. J Psychiatr Ment Health Nurs (2011) 0.85
Survival of patients with documented autologous recovery after SCT for severe aplastic anemia: a study by the WPSAA of the EBMT. Bone Marrow Transplant (2009) 0.85
Achieving hypoxia-inducible gene expression in tumors. Cancer Biol Ther (2005) 0.85
Characterization of a reference material for BCR-ABL (M-BCR) mRNA quantitation by real-time amplification assays: towards new standards for gene expression measurements. Leukemia (2007) 0.85
In silico mining identifies IGFBP3 as a novel target of methylation in prostate cancer. Br J Cancer (2007) 0.85
Neutrophils from AIDS patients treated with granulocyte colony-stimulating factor demonstrate enhanced killing of Mycobacterium avium. J Infect Dis (1998) 0.84
Segmental uniparental isodisomy on 5q32-qter in a patient with childhood-onset schizophrenia. J Med Genet (2006) 0.83
Upper airway obstruction during sleep in normal subjects after selective topical oropharyngeal anesthesia. Am Rev Respir Dis (1987) 0.83
Effects of nasal airflow on breathing during sleep in normal humans. Am Rev Respir Dis (1993) 0.83
Cystic fibrosis in adolescents and adults. Ir Med J (1992) 0.82
Breeding and Genetics Symposium: really big data: processing and analysis of very large data sets. J Anim Sci (2011) 0.82
Role of leukotrienes in antimicrobial defense of the lung. J Lab Clin Med (1998) 0.82
Radiation to control transgene expression in tumors. Cancer Biol Ther (2007) 0.82
Mid-infrared prediction of bovine milk fatty acids across multiple breeds, production systems, and countries. J Dairy Sci (2011) 0.82
Primary thromboprophylaxis for cancer patients with central venous catheters--a reappraisal of the evidence. Br J Cancer (2006) 0.81
The EORTC clinical research coordinators group. European Organisation for Research and Treatment of Cancer. Eur J Cancer (2002) 0.81
Monitoring of lineage-specific chimaerism allows early prediction of response following donor lymphocyte infusions for relapsed chronic myeloid leukaemia. Bone Marrow Transplant (1998) 0.81
Patterns of hematopoietic chimerism following bone marrow transplantation for childhood acute lymphoblastic leukemia from volunteer unrelated donors. Blood (1996) 0.81
Eye care utilisation patterns in a rural county in Ireland: implications for service delivery. Br J Ophthalmol (1997) 0.81
A chest radiograph scoring system in adult cystic fibrosis: correlation with pulmonary function. Clin Radiol (1991) 0.80
Sorting out mix-ups. The provenance of tissue sections may be confirmed by PCR using microsatellite markers. Am J Clin Pathol (1996) 0.79
High frequency of donor chimerism after allogeneic transplantation of CD34+-selected peripheral blood cells. Exp Hematol (1998) 0.79
Fludarabine, Cyclophosphamide and Rituximab: an effective chemoimmunotherapy combination with high remission rates for chronic lymphocytic leukaemia. Ir J Med Sci (2009) 0.78
Controlled infection with a therapeutic virus defines the activation kinetics of human natural killer cells in vivo. Clin Exp Immunol (2015) 0.78
Pyrrolo-1,5-benzoxazepines: a new class of apoptotic agents. Biochem Soc Trans (2001) 0.78
Frequency of deletion 508 among Irish cystic fibrosis patients. Hum Genet (1990) 0.78
Quality of life and survival in patients treated with radical chemoradiation alone for oesophageal cancer. Clin Oncol (R Coll Radiol) (2008) 0.78
Treatment of childhood obsessive compulsive disorder with clomipramine and desmethylimipramine: a double-blind crossover comparison. Psychopharmacol Bull (1988) 0.78
Cystic fibrosis in adolescents and adults. Ir Med J (1991) 0.78
Role of leukotrienes in antimicrobial host defense of the lung. Clin Rev Allergy Immunol (1999) 0.78
Hospital malnutrition: a 33-hospital screening study. J Am Diet Assoc (1986) 0.78
Incidence and significance of the JAK2 V617F mutation in patients with chronic myeloproliferative disorders. Ir J Med Sci (2007) 0.77
Studies on hemopoietic chimerism following allogeneic bone marrow transplantation in the molecular biology era. Leuk Res (1995) 0.77
Joint estimation of genetic parameters for test-day somatic cell count and mastitis in the United Kingdom. J Dairy Sci (2012) 0.77
Campath-1G in vivo confers a low incidence of graft-versus-host disease associated with a high incidence of mixed chimaerism after bone marrow transplantation for severe aplastic anaemia using HLA-identical sibling donors. Bone Marrow Transplant (1996) 0.77
Mixed chimaerism; detection and significance following BMT. Bone Marrow Transplant (1993) 0.77
Pulsed low dose rate brachytherapy in a rat model: dependence of late rectal injury on radiation pulse size. Int J Radiat Oncol Biol Phys (1997) 0.77
Pregnancy in women with Type 1 and Type 2 diabetes in Dublin. Ir J Med Sci (2011) 0.77
The tissue plasminogen activator gene promoter: a novel tool for radiogenic gene therapy of the prostate? J Gene Med (2008) 0.77
Thermolabile methylenetetrahydrofolate reductase (C677T): frequency in the Irish population. Ir J Med Sci (2002) 0.77
Transfusion-associated graft-versus-host disease, monoclonal gammopathy and PCR. Br J Haematol (1992) 0.77
Further evidence consistent with Yqh as an indicator of risk of gonadal blastoma in Y-bearing mosaic Turner syndrome. Clin Genet (1992) 0.77
Short communication: genetic relationships between the Holstein cow populations of three European dairy countries. J Dairy Sci (2009) 0.77
Recurrence of Philadelphia chromosome-positive leukemia in donor cells after bone marrow transplantation for chronic granulocytic leukemia. Leuk Lymphoma (1993) 0.77
Clinicopathologic factors predicting complete pathological response to neoadjuvant chemoradiotherapy in esophageal cancer. Dis Esophagus (2006) 0.76
Understanding the genetics of survival in dairy cows. J Dairy Sci (2013) 0.76
Aggressive treatment of ruptured abdominal aortic aneurysm in a community hospital. Surgery (1984) 0.76
Mid-infrared prediction of lactoferrin content in bovine milk: potential indicator of mastitis. Animal (2012) 0.76